Ozempic lowers cigarette and alcohol craving
A comprehensive American study has concluded that GLP-1 medications, such as Ozempic, reduce the likelihood of developing addictions to alcohol, nicotine, opioids, and cocaine by between 68% and 85%. The results showed that using these medications is associated with a significant decrease in addictive cravings, which researchers attribute to their effect on the brain's reward centers, although there remains a pressing need for clinical trials to confirm their effectiveness and safety in treating addiction.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)